Huang et al. [118] indicated the key role of miR-19-5p in the development and progression of CRC, via targeting TSP5, indicating that miR-19-5p could also be a useful biomarker for CRC patients, highlighting its potential implications for diagnoses and therapeutic interventions. The gene discussed is COMP; the disease is colorectal carcinoma.